Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 36

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 36
---
 employee or agent, or arising out of his status as such, whether or not the corporation
has the authority to indemnify him against such liability and expenses.

| II-1 |

Our Articles of Incorporation, as amended, and amended
and restated bylaws implement the indemnification and insurance provisions permitted by Chapter 78 of the NRS by providing that:

| · | We shall indemnify our directors and officers to the fullest extent permitted by the NRS against expense, liability and loss reasonably incurred or suffered by them in connection with their service as an officer or director; and |

| · | We may purchase and maintain insurance, or make other financial arrangements, on behalf of any person who holds or who has held a position as a director, officer, or representative against liability, cost, payment, or expense incurred by such person |

Item 15. Recent Sales of Unregistered Securities

The Company has not sold any securities within the
past three years which were not registered under the Securities Act except as set forth below. The registrant believes that, unless otherwise
noted, all of the transactions described in Item 15 were exempt from registration under the Securities Act pursuant to Section 4(a)(2)
of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

Equity Transaction with Acuitas

On July 15, 2022, the Company entered into a securities
purchase agreement with Acuitas Group Holdings, LLC (“Acuitas”), pursuant to which Acuitas agreed to purchase from the Company,
in a private placement, (i) an aggregate of 36,364 shares of the Company’s Common Stock at a price of $165.00 per share, and (ii)
a warrant to purchase 72,728 shares of Common Stock, at an exercise price of $2.50, with a term of exercise of five years. The warrant
has a down round feature that reduces the exercise price if the Company sells stock for lower price.

Placement Agent Warrants Issued in Connection with Offering on March 4, 2024

On March 4, 2024, the Company entered into a placement
agency agreement with ThinkEquity LLC, as the placement agent, in connection with the issuance and sale of up to 210,000 shares of Common
Stock, at a public offering price of $100.00 per share of Common Stock and/or pre-funded warrants to purchase shares of Common Stock at
a public offering price of $99.99